Recorded Chinese product: 复方樟柳碱注射液复方樟柳碱注射液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 华润紫竹药业有限公司Chinese legal name: 华润紫竹药业有限公司
主要成分Active Ingredients
- 氢溴酸樟柳碱Qingxiu Suanzhang Liujian
- 普鲁卡因Pulu Kayin
药物知识说明
氢溴酸樟柳碱是一种在国家药监局注册认定的药品。该药品含有普鲁卡因、氢溴酸樟柳碱-0d726167等成分。
该药品关联的活性成分包括:普鲁卡因Pulu Kayin、氢溴酸樟柳碱Qingxiu Suanzhang Liujian。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为:华润紫竹药业有限公司Chinese legal name: 华润紫竹药业有限公司。
您可以探索含有相同成分的其他药品:普鲁卡因-dbbfefd5成分药品。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 复方樟柳碱注射液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 普鲁卡因Pulu Kayin, 氢溴酸樟柳碱Qingxiu Suanzhang Liujian.
Manufacturers recorded for this product: 华润紫竹药业有限公司Chinese legal name: 华润紫竹药业有限公司.
Explore other medicines containing the same ingredient: 普鲁卡因 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 复方樟柳碱注射液Recorded Chinese product: 复方樟柳碱注射液
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 2ml*10支2 mL × 10 units
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 华润紫竹药业有限公司Chinese legal name: 华润紫竹药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20000495
关联实体Relationships
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20000495
Manufacturer
Chinese legal name: 华润紫竹药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
2 mL × 10 units
中文说明书原文Original Chinese source label
批准文号
国药准字H20000495
生产企业
华润紫竹药业有限公司(国产)
适应症
用于缺血性视神经、视网膜、脉络膜病变。
用法用量
患侧颞浅动脉旁皮下注射,一日一次,每次2ml(1支)(急重症者可加球旁注射,一日一次),14次为一疗程。据病情需要可注射2至4疗程。
不良反应
少数患者注射后轻度口干,15至20分钟消失。
禁忌
1、脑出血及眼出血急性期禁用。
2、有普鲁卡因过敏史者禁用。
注意事项
1、用过扩血管药和激素治疗无效者,可适当增加疗程。
2、青光眼和心房纤颤患者慎用。
贮藏
避光,30℃以下保存。
规格
2ml*10支
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.